328 related articles for article (PubMed ID: 24188096)
1. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
Domingo GJ; Satyagraha AW; Anvikar A; Baird K; Bancone G; Bansil P; Carter N; Cheng Q; Culpepper J; Eziefula C; Fukuda M; Green J; Hwang J; Lacerda M; McGray S; Menard D; Nosten F; Nuchprayoon I; Oo NN; Bualombai P; Pumpradit W; Qian K; Recht J; Roca A; Satimai W; Sovannaroth S; Vestergaard LS; Von Seidlein L
Malar J; 2013 Nov; 12():391. PubMed ID: 24188096
[TBL] [Abstract][Full Text] [Related]
2. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
Thriemer K; Ley B; Bobogare A; Dysoley L; Alam MS; Pasaribu AP; Sattabongkot J; Jambert E; Domingo GJ; Commons R; Auburn S; Marfurt J; Devine A; Aktaruzzaman MM; Sohel N; Namgay R; Drukpa T; Sharma SN; Sarawati E; Samad I; Theodora M; Nambanya S; Ounekham S; Mudin RN; Da Thakur G; Makita LS; Deray R; Lee SE; Boaz L; Danansuriya MN; Mudiyanselage SD; Chinanonwait N; Kitchakarn S; Nausien J; Naket E; Duc TN; Do Manh H; Hong YS; Cheng Q; Richards JS; Kusriastuti R; Satyagraha A; Noviyanti R; Ding XC; Khan WA; Swe Phru C; Guoding Z; Qi G; Kaneko A; Miotto O; Nguitragool W; Roobsoong W; Battle K; Howes RE; Roca-Feltrer A; Duparc S; Bhowmick IP; Kenangalem E; Bibit JA; Barry A; Sintasath D; Abeyasinghe R; Sibley CH; McCarthy J; von Seidlein L; Baird JK; Price RN
Malar J; 2017 Apr; 16(1):141. PubMed ID: 28381261
[TBL] [Abstract][Full Text] [Related]
3. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
[TBL] [Abstract][Full Text] [Related]
4. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
von Seidlein L; Auburn S; Espino F; Shanks D; Cheng Q; McCarthy J; Baird K; Moyes C; Howes R; Ménard D; Bancone G; Winasti-Satyahraha A; Vestergaard LS; Green J; Domingo G; Yeung S; Price R
Malar J; 2013 Mar; 12():112. PubMed ID: 23537118
[TBL] [Abstract][Full Text] [Related]
5. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
[TBL] [Abstract][Full Text] [Related]
6. Implementation of G6PD testing and primaquine for
Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
[TBL] [Abstract][Full Text] [Related]
7. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
8. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
[TBL] [Abstract][Full Text] [Related]
9. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Recht J; Ashley EA; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516
[TBL] [Abstract][Full Text] [Related]
10. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
11. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
12. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
13. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
[TBL] [Abstract][Full Text] [Related]
14. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
[TBL] [Abstract][Full Text] [Related]
16. Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Kondrashin A; Baranova AM; Ashley EA; Recht J; White NJ; Sergiev VP
Malar J; 2014 Feb; 13():51. PubMed ID: 24502194
[TBL] [Abstract][Full Text] [Related]
17. Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh.
Engel N; Ghergu C; Matin MA; Kibria MG; Thriemer K; Price RN; Ding XC; Howes RE; Ley B; Incardona S; Alam MS
Malar J; 2021 May; 20(1):217. PubMed ID: 33980257
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Sex-Stratified
Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
[TBL] [Abstract][Full Text] [Related]
19. Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study).
Santos A; Brito M; Silva E; Rocha F; Oliveira A; Dávila R; Gama H; Albuquerque J; Paiva M; Baía-Silva D; Sampaio V; Balieiro P; Rufatto R; Grewal Daumerie P; Peterka C; Edilson Lima F; Monteiro W; Arcanjo A; Silva R; Batista Pereira D; Lacerda M; Murta F
PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012197. PubMed ID: 38837977
[TBL] [Abstract][Full Text] [Related]
20. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI
Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
